Content Preview
Newsday/Optimum Online® subscribers click here for full access
Not a Newsday or Optimum Online® subscriber? Click here
Amityville's Hi-Tech Pharmacal licenses insomnia drug Zolpimist
Amityville-based Hi-Tech Pharmacal Co. Inc. has signed an exclusive licensing agreement between its ECR Pharmaceuticals subsidiary and drug development company NovaDel Pharma Inc. for a prescription medication to treat insomnia.
ECR obtained the rights to market zolpidem tartrate oral spray, or Zolpimist, in the United States and Canada.
Under terms of the agreement, ECR paid NovaDel,...
newsday.com is now available at no charge to Newsday and Optimum Online® subscribers. To continue reading, please log in or register now.
-
Already
registered on
newsday.com?
log in -
Already a subscriber
to Newsday or
Optimum Online®?
get access -
Not a Newsday
or Optimum Online®
subscriber?
click here
